Clinical Trial Update: Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on safety and pharmacokinetics of a fixed-dose combination of zidovudine, lamivudine, and nevirapine in HIV-infected children in Thailand …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Zidovudine/lamivudine/nevirapine fixed-dose combination

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED